Association for Research in Vision and Ophthalmology
Association for Research in Vision and Ophthalmology
May 03, 2018
1 min watch
Save

VIDEO: Iluvien can optimize DME treatment

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

HONOLULU — The PALADIN and USER studies found patients with diabetic macular edema who received an Iluvien implant (fluocinolone acetonide, Alimera Sciences) required less frequent anti-VEGF treatments, Victor Gonzalez, MD, said at the Association for Research in Vision and Ophthalmology meeting here.